sur Bayer Aktiengesellschaft (ETR:BAYN)
Bayer Adjusts Financial Guidance and Litigation Provisions for 2025
On July 31, 2025, Bayer AG announced an update to its financial projections for the year, ahead of its second-quarter results. The company has raised its currency-adjusted sales forecast to 46-48 billion euros and expects EBITDA before special items to be between 9.7 and 10.2 billion euros. Core earnings per share predictions have also increased, now estimated at 4.80 to 5.30 euros.
Bayer has also made significant legal provisions, particularly regarding the Roundup™ litigation in the US, setting aside an additional 1.2 billion euros. This decision impacts the company's overall special items, now forecasted at minus 3.5 to minus 2.5 billion euros for the whole year. Bayer aims to resolve most of its US litigation by the end of 2026.
The company continues to monitor geopolitical impacts, notably tariffs that might influence its financial outlook. Full second-quarter results will be released on August 6, 2025.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Bayer Aktiengesellschaft